U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Pseudohypoaldosteronism, type 2

MedGen UID:
259599
Concept ID:
C1449844
Disease or Syndrome
Synonym: Pseudohypoaldosteronism, Type II
SNOMED CT: Pseudohypoaldosteronism, type 2 (15689008); Gordon hyperkalemia-hypertension syndrome (703254001); Gordon hyperkalaemia-hypertension syndrome (703254001)
Modes of inheritance:
Autosomal recessive inheritance
MedGen UID:
141025
Concept ID:
C0441748
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in individuals with two pathogenic alleles, either homozygotes (two copies of the same mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele).
Autosomal dominant inheritance
MedGen UID:
141047
Concept ID:
C0443147
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele.
 
Genes (locations): CUL3 (2q36.2); KLHL3 (5q31.2); WNK1 (12p13.33); WNK4 (17q21.2)
 
Monarch Initiative: MONDO:0019162
OMIM®: 145260
OMIM® Phenotypic series: PS145260
Orphanet: ORPHA757

Disease characteristics

Excerpted from the GeneReview: Pseudohypoaldosteronism Type II
Pseudohypoaldosteronism type II (PHAII) is characterized by hyperkalemia despite normal glomerular filtration rate (GFR) and frequently by hypertension. Other associated findings in both children and adults include hyperchloremia, metabolic acidosis, and suppressed plasma renin levels. Aldosterone levels are variable, but are relatively low given the degree of hyperkalemia (elevated serum potassium is a potent stimulus for aldosterone secretion). Hypercalciuria is well described. [from GeneReviews]
Authors:
David H Ellison   view full author information

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVPseudohypoaldosteronism, type 2
Follow this link to review classifications for Pseudohypoaldosteronism, type 2 in Orphanet.

Professional guidelines

PubMed

Günay F, Şıklar Z, Berberoğlu M
Turk J Pediatr 2022;64(3):490-499. doi: 10.24953/turkjped.2021.1443. PMID: 35899562
Bandhakavi M, Wanaguru A, Ayuk L, Kirk JM, Barrett TG, Kershaw M, Högler W, Shaw NJ
Eur J Endocrinol 2021 May;184(5):K15-K20. doi: 10.1530/EJE-20-0152. PMID: 33690157
Memoli E, Lava SAG, Bianchetti MG, Vianello F, Agostoni C, Milani GP
Pediatr Nephrol 2020 Apr;35(4):713-714. Epub 2019 Dec 20 doi: 10.1007/s00467-019-04419-z. PMID: 31863208

Recent clinical studies

Etiology

Khandelwal P, Deinum J
Pediatr Nephrol 2022 Jul;37(7):1495-1509. Epub 2021 Aug 20 doi: 10.1007/s00467-021-05246-x. PMID: 34414500
Melcescu E, Phillips J, Moll G, Subauste JS, Koch CA
Horm Metab Res 2012 Nov;44(12):867-78. Epub 2012 Aug 29 doi: 10.1055/s-0032-1321851. PMID: 22932914
Cope G, Golbang A, O'Shaughnessy KM
Pharmacol Ther 2005 May;106(2):221-31. Epub 2005 Jan 26 doi: 10.1016/j.pharmthera.2004.11.010. PMID: 15866321

Diagnosis

Khandelwal P, Deinum J
Pediatr Nephrol 2022 Jul;37(7):1495-1509. Epub 2021 Aug 20 doi: 10.1007/s00467-021-05246-x. PMID: 34414500
Monticone S, Losano I, Tetti M, Buffolo F, Veglio F, Mulatero P
Clin Endocrinol (Oxf) 2018 Oct;89(4):385-396. Epub 2018 Jun 6 doi: 10.1111/cen.13741. PMID: 29758100
O'Shaughnessy KM
Pediatr Nephrol 2015 Nov;30(11):1903-8. Epub 2014 Dec 11 doi: 10.1007/s00467-014-2956-7. PMID: 25503323
Melcescu E, Phillips J, Moll G, Subauste JS, Koch CA
Horm Metab Res 2012 Nov;44(12):867-78. Epub 2012 Aug 29 doi: 10.1055/s-0032-1321851. PMID: 22932914
Luft FC, Toka O, Toka HR, Jordan J, Bahring S
Am J Physiol Regul Integr Comp Physiol 2003 Oct;285(4):R709-14. doi: 10.1152/ajpregu.00174.2003. PMID: 12959913

Therapy

Yavas Abali Z, Yesil G, Kirkgoz T, Cicek N, Alpay H, Turan S, Bereket A, Guran T
Pediatr Nephrol 2020 Mar;35(3):405-407. Epub 2019 Sep 16 doi: 10.1007/s00467-019-04352-1. PMID: 31529157
Bergaya S, Vidal-Petiot E, Jeunemaitre X, Hadchouel J
Curr Opin Nephrol Hypertens 2012 Jan;21(1):39-45. doi: 10.1097/MNH.0b013e32834d2fde. PMID: 22080857

Prognosis

Khandelwal P, Deinum J
Pediatr Nephrol 2022 Jul;37(7):1495-1509. Epub 2021 Aug 20 doi: 10.1007/s00467-021-05246-x. PMID: 34414500

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...